Immunovant Sciences Gmbh
Clinical trials sponsored by Immunovant Sciences Gmbh, explained in plain language.
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis study tested a drug called batoclimab in 114 adults with active thyroid eye disease, a condition that causes eye bulging and inflammation. Participants received weekly injections of batoclimab or a placebo for 24 weeks. The main goal was to see if batoclimab could reduce eye…
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 17, 2026 06:20 UTC
-
New drug shows promise for Hard-to-Treat Graves' disease
Disease control CompletedThis study tested a drug called batoclimab in 35 adults with Graves' disease whose thyroid levels remained high despite standard antithyroid medications. The goal was to see if 24 weeks of treatment could bring thyroid hormones back to normal or below normal without increasing th…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 11, 2026 20:47 UTC